News
VH1 Announces Competitive Weight Loss Series 'Money Hungry'
With America's obesity epidemic at an all-time high, the struggle to shed pounds has become an obsession. But what many Americans are finding is that good health and good looks aren't motivation enough to put down the fries. So this summer, VH1 is giving viewers a never-before-seen comedic look at a weight loss competition using the greatest American motivator of all... MONEY! That's right, "Money Hungry," premiering Monday, August 2 at 9:00 PM* puts $10,000 of the contestants' own money on the line to encourage them to drop those unwanted pounds once and for all. Tune in to see the drama, laughs and tears as these overweight teams fight to lose their fat and not their money!
ObesitySolvers Launches Website to Address Childhood Obesity
ObesitySolvers launched a website in response to Center for Science
in the Public Interest's (CSPI) lawsuit against McDonald's Happy Meal
Toys. The site includes content from news sources which addresses
ways to fight obesity such as exercise, eating habits, lifestyle,
environment and education.
Bob Cutler, CEO of Creative Consumer Concepts (C3), said that in
order to fight childhood obesity, the focus needs to be on actual
solutions and not on limiting consumer choices. "While government
issued information is beneficial, zealous and selfish legislation
FDA Warning Labels Not Needed for mirafit fbcx(R) Weight Loss Supplement
Yesterday, the U.S. Food & Drug Administration announced it is requiring a new warning about potential liver injury to be placed on the weight-loss drugs Xenical and Alli.
These medications used for weight-loss that contain different strengths of the same active ingredient, orlistat, a derivative of lipstatin, an inhibitor of pancreatic enzymes that prevents the breakdown of fat molecules.
America's Healthiest Diet Launches S.H.O.W.
Structure House, a world-renowned residential weight loss center, recently launched an online version of its successful 28-day plan, called Structure House Online Weight Loss, or S.H.O.W. The virtual program will allow at-home access to Structure House's proven behavioral approach to healthy weight loss.
GMA Applauds Rep. Ron Kind's Comprehensive Obesity Legislation
The Grocery Manufacturers Association (GMA) today commended U.S. Rep. Ron Kind and his fellow cosponsors for introducing comprehensive obesity legislation, The Healthy CHOICES Act.
SoLo Bars Validated by Athletes and Researchers
SoLo’s Controlled Energy Response Technology™ has been validated by leading University researchers. SoLo’s high performance nutrition delivers a slow and steady release of fuel; providing lasting energy, enhanced endurance and consistent results - allowing athletes to perform at their best, over extended periods of time.
'Who's Who' Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets
Martin Schiff, M.D. has been a bariatric weight-control specialist in Los Angeles for more than half a century, as shown in "Who's Who in America," "Who's Who in the World," and "Who's Who in Medicine and Health Care."
Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone
Medifast, Inc. today announced that a recent study published in 'The Journal of Eating and Weight Disorders' shows that individuals taking appetite suppressant medications can expect double the weight loss when they combine their drug therapy with a medical protocol using Medifast Meal Replacement Supplements.
Fourth-annual Danialle Karmanos' Work It Out Get Fit Day Continues to Lead Fight Against Childhood Obesity
Danialle Karmanos' Work It Out (DKWIO), a dynamic not-for-profit program dedicated to the physical, mental and spiritual wellness of children, today announced that it will host its fourth-annual Get Fit Day in Detroit's Campus Martius Park on July 30. Through holistic programming, Get Fit Day and DKWIO provide at-risk kids with the tools they need to make healthy choices.
Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine at CBI Obesity Summit
Genaera Corporation today announced interim Phase 1 safety and pharmacokinetic (PK) data and new preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, during the CBI 4th Annual Obesity Drug Development Summit in Arlington, Virginia.